Literature DB >> 33401749

Role of Melatonin on Virus-Induced Neuropathogenesis-A Concomitant Therapeutic Strategy to Understand SARS-CoV-2 Infection.

Prapimpun Wongchitrat1, Mayuri Shukla2, Ramaswamy Sharma3, Piyarat Govitrapong2, Russel J Reiter3.   

Abstract

Viral infections may cause neurological disorders by directly inducing oxidative stress and interrupting immune system function, both of which contribute to neuronal death. Several reports have described the neurological manifestations in Covid-19 patients where, in severe cases of the infection, brain inflammation and encephalitis are common. Recently, extensive research-based studies have revealed and acknowledged the clinical and preventive roles of melatonin in some viral diseases. Melatonin has been shown to have antiviral properties against several viral infections which are accompanied by neurological symptoms. The beneficial properties of melatonin relate to its properties as a potent antioxidant, anti-inflammatory, and immunoregulatory molecule and its neuroprotective effects. In this review, what is known about the therapeutic role of melatonin in virus-induced neuropathogenesis is summarized and discussed.

Entities:  

Keywords:  Covid-19; anti-inflammation; melatonin; neurodegeneration; oxidative stress; reactive oxygen species; viral infection

Year:  2021        PMID: 33401749      PMCID: PMC7823793          DOI: 10.3390/antiox10010047

Source DB:  PubMed          Journal:  Antioxidants (Basel)        ISSN: 2076-3921


  195 in total

1.  Melatonin inhibits the sphingosine kinase 1/sphingosine-1-phosphate signaling pathway in rabbits with fulminant hepatitis of viral origin.

Authors:  Irene Crespo; Beatriz San-Miguel; Diana I Sánchez; Bárbara González-Fernández; Marcelino Álvarez; Javier González-Gallego; María J Tuñón
Journal:  J Pineal Res       Date:  2016-05-22       Impact factor: 13.007

2.  Virus entry and replication in the brain precedes blood-brain barrier disruption during intranasal alphavirus infection.

Authors:  Matthew D Cain; Hamid Salimi; Yongfeng Gong; Lihua Yang; Samantha L Hamilton; James R Heffernan; Jianghui Hou; Mark J Miller; Robyn S Klein
Journal:  J Neuroimmunol       Date:  2017-05-01       Impact factor: 3.478

Review 3.  Melatonin and the theories of aging: a critical appraisal of melatonin's role in antiaging mechanisms.

Authors:  Rüdiger Hardeland
Journal:  J Pineal Res       Date:  2013-09-23       Impact factor: 13.007

Review 4.  Melatonin and their analogs as a potential use in the management of Neuropathic pain.

Authors:  Yaswanth Kuthati; Sheng-Hsiung Lin; Ing-Jung Chen; Chih-Shung Wong
Journal:  J Formos Med Assoc       Date:  2018-10-10       Impact factor: 3.282

5.  A rat model of Parkinson's disease induced by Japanese encephalitis virus.

Authors:  A Ogata; K Tashiro; S Nukuzuma; K Nagashima; W W Hall
Journal:  J Neurovirol       Date:  1997-04       Impact factor: 2.643

6.  Melatonin from cerebrospinal fluid but not from blood reaches sheep cerebral tissues under physiological conditions.

Authors:  C Legros; D Chesneau; J A Boutin; C Barc; B Malpaux
Journal:  J Neuroendocrinol       Date:  2014-03       Impact factor: 3.627

7.  A study of motor activity and catecholamine levels in different brain regions following Japanese encephalitis virus infection in rats.

Authors:  Usha Kant Misra; Sandeep Kumar; Jayantee Kalita; Ausaf Ahmad; Vinay Kumar Khanna; Mohammad Yahiya Khan; Gautam Palit
Journal:  Brain Res       Date:  2009-07-22       Impact factor: 3.252

8.  Protective effects of melatonin and selenium against apoptosis of olfactory sensory neurons: A rat model study.

Authors:  Sema Koc; Sevil Cayli; Ceyhun Aksakal; Seda Ocakli; Harun Soyalic; Battal Tahsin Somuk; Salim Yüce
Journal:  Am J Rhinol Allergy       Date:  2016-05       Impact factor: 2.467

9.  Antiinflammatory activity of melatonin in central nervous system.

Authors:  Emanuela Esposito; Salvatore Cuzzocrea
Journal:  Curr Neuropharmacol       Date:  2010-09       Impact factor: 7.363

Review 10.  Melatonin and Ischemic Stroke: Mechanistic Roles and Action.

Authors:  Syed Suhail Andrabi; Suhel Parvez; Heena Tabassum
Journal:  Adv Pharmacol Sci       Date:  2015-09-07
View more
  8 in total

1.  Concentrated Growth Factors (CGF) Combined with Melatonin in Guided Bone Regeneration (GBR): A Case Report.

Authors:  Alessandro Leonida; Gaia Favero; Paolo Caccianiga; Saverio Ceraulo; Luigi Fabrizio Rodella; Rita Rezzani; Gianluigi Caccianiga
Journal:  Diagnostics (Basel)       Date:  2022-05-18

2.  Dietary Supplements and Nutraceuticals Under Investigation for COVID-19 Prevention and Treatment.

Authors:  Ronan Lordan; Halie M Rando; Casey S Greene
Journal:  ArXiv       Date:  2021-02-03

Review 3.  Nanotechnology Frontiers in γ-Herpesviruses Treatments.

Authors:  Marisa Granato
Journal:  Int J Mol Sci       Date:  2021-10-22       Impact factor: 5.923

4.  Is Phytomelatonin Complex Better Than Synthetic Melatonin? The Assessment of the Antiradical and Anti-Inflammatory Properties.

Authors:  Wirginia Kukula-Koch; Dominik Szwajgier; Katarzyna Gaweł-Bęben; Marcelina Strzępek-Gomółka; Kazimierz Głowniak; Henry O Meissner
Journal:  Molecules       Date:  2021-10-08       Impact factor: 4.411

Review 5.  Melatonin: highlighting its use as a potential treatment for SARS-CoV-2 infection.

Authors:  Russel J Reiter; Ramaswamy Sharma; Fedor Simko; Alberto Dominguez-Rodriguez; Jan Tesarik; Richard L Neel; Andrzej T Slominski; Konrad Kleszczynski; Verna M Martin-Gimenez; Walter Manucha; Daniel P Cardinali
Journal:  Cell Mol Life Sci       Date:  2022-02-20       Impact factor: 9.207

Review 6.  Basic mechanisms of SARS-CoV-2 infection. What endocrine systems could be implicated?

Authors:  Manel Puig-Domingo; Mónica Marazuela; Berta Soldevila
Journal:  Rev Endocr Metab Disord       Date:  2021-07-31       Impact factor: 9.306

7.  Melatonin and Related Compounds: Antioxidant and Anti-Inflammatory Actions.

Authors:  Maria Bantounou; Josip Plascevic; Helen F Galley
Journal:  Antioxidants (Basel)       Date:  2022-03-10

Review 8.  The Coronavirus Disease 2019 (COVID-19): Key Emphasis on Melatonin Safety and Therapeutic Efficacy.

Authors:  Eva Ramos; Francisco López-Muñoz; Emilio Gil-Martín; Javier Egea; Iris Álvarez-Merz; Sakshi Painuli; Prabhakar Semwal; Natália Martins; Jesús M Hernández-Guijo; Alejandro Romero
Journal:  Antioxidants (Basel)       Date:  2021-07-20
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.